BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23226201)

  • 21. Angiogenesis-promoting gene patterns in alveolar soft part sarcoma.
    Lazar AJ; Das P; Tuvin D; Korchin B; Zhu Q; Jin Z; Warneke CL; Zhang PS; Hernandez V; Lopez-Terrada D; Pisters PW; Pollock RE; Lev D
    Clin Cancer Res; 2007 Dec; 13(24):7314-21. PubMed ID: 18094412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein.
    Kobos R; Nagai M; Tsuda M; Merl MY; Saito T; Laé M; Mo Q; Olshen A; Lianoglou S; Leslie C; Ostrovnaya I; Antczak C; Djaballah H; Ladanyi M
    J Pathol; 2013 Apr; 229(5):743-754. PubMed ID: 23288701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal-deficient alveolar soft-part sarcoma with cutaneous involvement: a case report.
    Kacerovska D; Michal M; Nemcova J; Vanecek T; Kreuzberg B; Mrazkova P; Koudela K; Kazakov DV
    Am J Dermatopathol; 2009 May; 31(3):272-7. PubMed ID: 19384069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ASPL-TFE3 translocation in vulvovaginal alveolar soft part sarcoma.
    Jabbour MN; Seoud M; Al-Ahmadie H; Abdul-Karim FW; Zaatari GS
    Int J Gynecol Pathol; 2014 May; 33(3):263-7. PubMed ID: 24681737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment and characterization of a renal cell carcinoma cell line (FU-UR-1) with the reciprocal ASPL-TFE3 fusion transcript.
    Ishiguro M; Iwasaki H; Ohjimi Y; Kaneko Y
    Oncol Rep; 2004 Jun; 11(6):1169-75. PubMed ID: 15138551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.
    Pradhan D; Roy S; Quiroga-Garza G; Cieply K; Mahaffey AL; Bastacky S; Dhir R; Parwani AV
    Diagn Pathol; 2015 Sep; 10():179. PubMed ID: 26415891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alveolar Soft Part Sarcoma of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases With Emphasis on its Distinction From Morphologic Mimics.
    Schoolmeester JK; Carlson J; Keeney GL; Fritchie KJ; Oliva E; Young RH; Nucci MR
    Am J Surg Pathol; 2017 May; 41(5):622-632. PubMed ID: 28009610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TFE3 immunoreactivity in alveolar soft part sarcoma of the uterine cervix: case report.
    Roma AA; Yang B; Senior ME; Goldblum JR
    Int J Gynecol Pathol; 2005 Apr; 24(2):131-5. PubMed ID: 15782069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Technique for differentiating alveolar soft part sarcoma from other tumors in paraffin-embedded tissue: comparison of immunohistochemistry for TFE3 and CD147 and of reverse transcription polymerase chain reaction for ASPSCR1-TFE3 fusion transcript.
    Tsuji K; Ishikawa Y; Imamura T
    Hum Pathol; 2012 Mar; 43(3):356-63. PubMed ID: 21835426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lingual Alveolar Soft Part Sarcoma in a 1-Year-Old Infant: Youngest Reported Case With Characteristic ASPSCR1-TFE3 Fusion.
    Ruffle A; Cameron M; Jonas N; Levine S; Mills C; Hook CE; Murray MJ
    Pediatr Dev Pathol; 2019; 22(4):391-395. PubMed ID: 30744536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay.
    Argani P; Lal P; Hutchinson B; Lui MY; Reuter VE; Ladanyi M
    Am J Surg Pathol; 2003 Jun; 27(6):750-61. PubMed ID: 12766578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma.
    Tanaka M; Chuaychob S; Homme M; Yamazaki Y; Lyu R; Yamashita K; Ae K; Matsumoto S; Kumegawa K; Maruyama R; Qu W; Miyagi Y; Yokokawa R; Nakamura T
    Nat Commun; 2023 Apr; 14(1):1957. PubMed ID: 37029109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial.
    Lee CJ; Modave E; Boeckx B; Kasper B; Aamdal S; Leahy MG; Rutkowski P; Bauer S; Debiec-Rychter M; Sciot R; Lambrechts D; Wozniak A; Schöffski P
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment and characterization of NCC-ASPS2-C1: a novel patient-derived cell line of alveolar soft part sarcoma.
    Osaki J; Noguchi R; Yanagihara K; Ono T; Adachi Y; Iwata S; Toda Y; Sekita T; Kobayashi E; Kojima N; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2024 May; 37(3):865-873. PubMed ID: 38478355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of neoplasms with MITF/MiT family translocations.
    Wei S; Testa JR; Argani P
    Histol Histopathol; 2022 Apr; 37(4):311-321. PubMed ID: 35107169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of immunohistochemistry and FISH of TFE3 in the diagnosis of alveolar soft part sarcoma: A case report.
    Huang YY; Yang WR; Geng YH; Zhang Y
    Medicine (Baltimore); 2022 Jul; 101(27):e29861. PubMed ID: 35801771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.
    Argani P; Zhong M; Reuter VE; Fallon JT; Epstein JI; Netto GJ; Antonescu CR
    Am J Surg Pathol; 2016 Jun; 40(6):723-37. PubMed ID: 26975036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of MET in alveolar soft part sarcoma.
    Jun HJ; Lee J; Lim DH; Park JO; Ahn G; Seo SW; Sung KS; Lim DH; Yoo KH; Choi YL
    Med Oncol; 2010 Jun; 27(2):459-65. PubMed ID: 19472090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21).
    Argani P; Antonescu CR; Couturier J; Fournet JC; Sciot R; Debiec-Rychter M; Hutchinson B; Reuter VE; Boccon-Gibod L; Timmons C; Hafez N; Ladanyi M
    Am J Surg Pathol; 2002 Dec; 26(12):1553-66. PubMed ID: 12459622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23).
    Argani P; Lui MY; Couturier J; Bouvier R; Fournet JC; Ladanyi M
    Oncogene; 2003 Aug; 22(34):5374-8. PubMed ID: 12917640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.